Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Test Detects Tumor Markers Using Laser-Stimulated Fluorescence

By LabMedica International staff writers
Posted on 09 Apr 2014
Tumor markers in the blood help determine whether the patient is afflicted with a malign tumor and whether it is excreting markers more vigorously involving highly specific proteins.

An increased concentration in the blood provides one indication of the disease for physicians, but it has been quite expensive in time and effort to detect the markers thus far and to be able to detect a single specific one, scientists must first separate and purify the blood in several steps and then isolate the marker.

Scientists at the Fraunhofer Institute for Manufacturing Engineering and Automation IPA (Mannheim, Germany) have developed a one-step analysis to detect tumor biomarkers. More...
The difficulty in detecting specific molecules in the blood or urine lies in the enormous number of substances that are mixed in the sample. They cause a high level of background noise that masks the desired signal and the signal from the protein being searched for can no longer be distinguished.

To improve the signal to noise ratio, the scientists used magnetic beads, which are particles only a few micrometers in size that have a magnetic core. If a magnet is positioned externally on the test tube, the beads can be arrested or steered. This technique is already in use. To isolate molecules from a solution like blood, the surface of the beads with were coated with specialized antibodies. The proteins that are being searched for wind past the beads, and the antibodies attach to them. If the magnet is held to the outside of the test tube, the beads together with the desired proteins stick to the interior surface of the tube, while the rest of the solution can be easily removed.

Additional means were developed with the samples exposed to the coated beads, but also to additional antibodies that have fluorescent markers bound to them. These antibodies attach themselves to the proteins being searched for and cause them to fluoresce. The optical signal is very weak though, and would normally disappear in the background noise. When using an alternating magnetic field, the magnetic beads flock together in rhythm, and the fluorescent markers bound to the surfaces emit their light in synchrony and radiate considerably more brightly than any given bead by itself. The advantage of this visualization technique is that the optical signal provides immediate insight about whether a tumor marker protein is present in the blood. The analysis equipment was presented at the Analytica international trade fair held April 1–4, 2014, in Munich (Germany).

Related Links:

Fraunhofer Institute for Manufacturing Engineering and Automation



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.